Avastin
![Keytruda: Merckās cancer drug shines and falters at ESMO](https://pharmtales.com/wp-content/uploads/2023/10/Keytruda_-Mercks-breakthrough-cancer-drug-with-mixed-results-at-ESMO.jpg)
Keytruda: Merckās breakthrough cancer drug with mixed results at ESMO
Anika Sharma
Merck & Co. made significant strides at this year’s European Society for Medical Oncology (ESMO) congress, presenting a series of ...
![Lytenava, Outlook Therapeutics, Avastin, Roche, wet AMD, bevacizumab-vikg, Complete response letter](https://pharmtales.com/wp-content/uploads/2023/08/Outlooks-eye-drug-Lytenava-fails-to-win-FDA-approval-despite-positive-trial.jpg)
Outlookās eye drug Lytenava fails to win FDA approval, despite positive trial
Anika Sharma
Outlook Therapeutics has been working on a reformulated version of Rocheās cancer drug Avastin for the treatment of certain eye ...